Narayanan and Liotta testing therapeutic efficacy of potential COVID-19 treatments

(George Mason University) Aarthi Narayanan, Associate Professor, and Lance Liotta, Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM), are conducting three studies to assess the therapeutic efficacy of candidate interventions for COVID-19 in mouse models.